1-9 of 9
Jessica Hochberg
Close
Sort by
Journal Articles

Multicenter Pilot Trial of Intrathecal Liposomal Cytarabine Combined with FAB Chemoimmunotherapy with Reduced Doxorubicin in CAYA with Mature De-Novo B-NHL

Anthony N. Audino, Stanton Goldman, Matthew J. Barth, Jessica Hochberg, Ana C. Xavier, Bruce Shiramizu, Qiuhu Shi, Lauren Harrison, Jackie Basso, Javier Oesterheld, Kenneth Matthew Heym, Richard A. Drachtman, Paul Harker-Murray, Sherrie L. Perkins, Rodney R. Miles, Mitchell S. Cairo
Journal: Blood
Blood (2023) 142 (Supplement 1): 1727.
https://doi.org/10.1182/blood-2023-181756
Published: 2023
Journal Articles

Targeted Immunotherapy and Checkpoint Blockade in Children, Adolescents, and Young Adults with Lymphoma: Radical Hodgkin Cohort

Kayleigh Klose, Jessica Hochberg, Jaclyn Basso, Ana C. Xavier, Matthew J. Barth, Rodney R. Miles, Samir Kahwash, Stephan D. Voss, Suzanne Braniecki, Chitti Moorthy, Saro Armenian, Matthew J. Ehrhardt, Megan Lim, Lauren Harrison, Arvind Budhram, Ariel Stonberg, Stanton Goldman, Mitchell S. Cairo
Journal: Blood
Blood (2023) 142 (Supplement 1): 3083.
https://doi.org/10.1182/blood-2023-186691
Published: 2023
Journal Articles

A Phase II Study to Evaluate the Safety and Efficacy of Defibrotide and Changes in Plasma Biomarkers in Sickle Cell Disease-Related Acute Chest Syndrome (IND 127812)

Edo Schaefer, Morgan Anderson-Crannage, Jessica Hochberg, Temima Kanarfogel, Yiouli Panayiota Ktena, John Herrick, Emily Thatcher, Qiuhu Shi, Bruno Hochberg, Yaya Chu, Sankaran Krishnan, Erin Morris, Sandra Fabricatore, John DuFresne, Kenneth R. Cooke, Mitchell S. Cairo
Journal: Blood
Blood (2023) 142 (Supplement 1): 2520.
https://doi.org/10.1182/blood-2023-180804
Published: 2023
Journal Articles

Expanded Natural Killer (NK) Cells Transfected with Anti-CD20 Chimeric Antigen Receptor (CAR) mRNA Have Significant Cytotoxicity Against Poor Risk B-Cell (CD20 + ) Leukemia/Lymphoma (B-L/L).

Yaya Chu, PhD, Janet Ayello, MS, MT(ASCP), Lowrence Lo, Jared Katz, Ashlin Yahr, Jessica Hochberg, MD, Carmella van de Ven, MA, Xianzheng Zhou, MD, PhD, Mitchell S. Cairo, MD
Journal: Blood
Blood (2012) 120 (21): 3007.
https://doi.org/10.1182/blood.V120.21.3007.3007
Published: 2012
Journal Articles

Safety of Liposomal Cytarabine Prophylaxis in Pediatric Bone Marrow Transplant (BMT) Recipients with Acute Leukemia (AL) and Non Hodgkin Lymphoma (NHL) At High Risk of CNS Relapse

Jessica Hochberg, MD, Deirdre Duffy, BS, Lauren Harrison, RN, MSN, Erin Morris, RN, Mitchell S. Cairo, MD
Journal: Blood
Blood (2011) 118 (21): 4249.
https://doi.org/10.1182/blood.V118.21.4249.4249
Published: 2011
Journal Articles

Genetically Engineered Natural Killer (NK) Cell Immunotherapy for Poor Risk B-Cell (CD20 + ) Leukemia and Lymphoma

Yaya Chu, PhD, Janet Ayello, MS, MT(ASCP), Jessica Hochberg, MD, Carmella vandeVen, MA, James Murphy, Andrew Stier, Mitchell S. Cairo, MD
Journal: Blood
Blood (2011) 118 (21): 1003.
https://doi.org/10.1182/blood.V118.21.1003.1003
Published: 2011
Journal Articles

Genetically Reengineered K562 Cells Significantly Expand Cord Blood (CB) Natural Killer (NK) Cells Ex-Vivo Expanded with Increased NK Cell Activation and Cytolytic Activity Both In-Vitro and In-Vivo: Potential Use In Adoptive Cellular Immunotherapy (ACI)

Michele Levin, MD, Janet Ayello, MS, MT(ASCP), Frances Zhao, MS, Andrew Stier, Lauren Tiffen, William Quish, Carmella vandeVen, MA, Laxmi V. Baxi, MD, Jessica Hochberg, MD, Mitchell S. Cairo, MD
Journal: Blood
Blood (2010) 116 (21): 3928.
https://doi.org/10.1182/blood.V116.21.3928.3928
Published: 2010
Journal Articles

Significant Ex-Vivo Expansion and Functional Activation of Cord Blood (CB) Natural Killer (NK) Cells with A Concomittant Significant Decrease in CB T Cells Following Stimulation with Genetically Engineered K562 Cells (K562-mb15-41BBL).

Jessica Hochberg, MD, Janet Ayello, MS, MT, Carmella VandeVen, MS, Jeremy Gold, Evan Cairo, Frances Zhao, Mitchell S. Cairo, MD
Journal: Blood
Blood (2009) 114 (22): 499.
https://doi.org/10.1182/blood.V114.22.499.499
Published: 2009
Journal Articles

Genetic Engineering and Significant Ex-Vivo Expansion of Cord Blood Natural Killer Cells: Implications for Post-Transplant Adoptive Cellular Immunotherapy

Jessica Hochberg, MD, Brenton Mar, MD, Janet Ayello, MS, MT, Nancy Day, Carmella van de Ven, Angela Ricci, Lalit Gurnani, Evan Cairo, Dario Campana, MD., PhD, Mitchell S. Cairo
Journal: Blood
Blood (2008) 112 (11): 209.
https://doi.org/10.1182/blood.V112.11.209.209
Published: 2008